Merops Switch to
Peptidases

Inhibitor

Family Clan Small-molecule
inhibitor SEARCHES BLAST
MEROPS

Other
information

Literature for inhibitor I04.024: C1 inhibitor

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Inhibits

(Topics flags: S Structure, M Mutation, I Inhibitor, K Knockout, E Expression, V Review, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

    2026
  1. No,a.l.
    C1 Esterase Inhibitor
     (2026) PubMed  Europe PubMed
    2. 2025
  2. Bernstein,J.A., Cheng,J., Pisani,T., Sexton,D., Whitaker,R.E., Nova Estepan,D. and Inhaber,N.
    Clinical validity of dried blood spot assay for the measurement of functional C1 inhibitor in angioedema due to C1 inhibitor deficiency
    J Allergy Clin Immunol Glob (2025) 4, 100401-100401. PubMed  Europe PubMed DOI  PMC  EPMC
  3. Ren,Z., Bao,J., Zhao,S., Pozzi,N., Wedner,H. and Atkinson,J.P.
    N-glycosylation in the SERPIN domain of C1-Esterase Inhibitor in hereditary angioedema
    JCI Insight (2025) PubMed  Europe PubMed DOI
  4. Shen,Y., Dong,X., Li,X., Shi,Z., Shao,T., Jiang,J. and Song,J.
    WNT inhibitor SP5-mediated SERPING1 suppresses lung adenocarcinoma progression via TSC2/mTOR pathway
    Cell Death Dis (2025) 16, 103-103. PubMed  Europe PubMed DOI  PMC  EPMC
    5. 2024
  5. Garrigues,R.J., Garrison,M.P. and Garcia,B.L.
    The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation
    J Immunol (2024) 213, 718-729. PubMed  Europe PubMed DOI
  6. Riedl,M.A., Bordone,L., Revenko,A., Newman,K.B. and Cohn,D.M.
    Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema
    J Allergy Clin Immunol Pract (2024) 12, 911-918. PubMed  Europe PubMed DOI  K
    7. 2023
  7. [YEAR:15-8-2023]
    C1 Esterase Inhibitor
     (15-8-2023) PubMed  Europe PubMed
  8. Miyata,T. and Horiuchi,T.
    Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency
    Allergol Int (2023) 72, 375-384. PubMed  Europe PubMed DOI
    9. 2022
  9. Al-Kuraishy,H.M., Al-Gareeb,A.I., Jalal,N.A., Kabrah,S.M., Alexiou,A. and Batiha,G.E.
    SARS-CoV-2 Infection and C1-Esterase Inhibitor: Camouflage Pattern and New Perspective
    Curr Protein Pept Sci (2022) 23, 465-474. PubMed  Europe PubMed DOI
  10. Alfaro,E., Diaz-Garcia,E., Garcia-Tovar,S., Zamarron,E., Mangas,A., Galera,R., Nanwani-Nanwani,K., Perez-de-Diego,R., Lopez-Collazo,E., Garcia-Rio,F. and Cubillos-Zapata,C.
    Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
    Front Immunol (2022) 13, 909342-909342. PubMed  Europe PubMed DOI  PMC  EPMC
  11. Gramstad,O.R., Kandanur,S.P.S., Etscheid,M., Nielsen,E.W. and Kanse,S.M.
    Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency
    Mol Immunol (2022) 142, 95-104. PubMed  Europe PubMed DOI
  12. Hurler,L., Toonen,E.J.M., Kajdacsi,E., van Bree,B., Brandwijk,R.J.M.G., de Bruin,W., Lyons,P.A., Bergamaschi,L., Sinkovits,G., Cervenak,L., Wurzner,R. and Prohaszka,Z.
    Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
    Front Immunol (2022) 13, 1039765-1039765. PubMed  Europe PubMed DOI  PMC  EPMC
    13. 2021
  13. Karnaukhova,E.
    C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development
    Curr Med Chem (2021) PubMed  Europe PubMed DOI
    14. 2020
  14. Hor,L., Pan,J., Whisstock,J.C., Pike,R.N. and Wijeyewickrema,L.C.
    Mapping the binding site of C1-inhibitor for polyanion cofactors
    Mol Immunol (2020) 126, 8-13. PubMed  Europe PubMed DOI
  15. Marceau,F., Rivard,G.E., Gauthier,J.M., Binkley,K.E., Bonnefoy,A., Boccon-Gibod,I., Bouillet,L., Picard,M., Levesque,G., Elfassy,H.L., Bachelard,H., Hebert,J. and Bork,K.
    Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
    Front Med (Lausanne) (2020) 7, 358-358. PubMed  Europe PubMed DOI  PMC  EPMC  I
  16. Ponard,D., Gaboriaud,C., Charignon,D., Ghannam,A., Wagenaar-Bos,I.G.A., Roem,D., Lopez-Lera,A., Lopez-Trascasa,M., Tosi,M. and Drouet,C.
    SERPING1 mutation update: mutation spectrum and C1 inhibitor phenotypes
    Hum Mutat (2020) 41, 38-57. PubMed  Europe PubMed DOI  M
  17. Verbree-Willemsen,L., Zhang,Y.N., Ibrahim,I., Ooi,S.B.S., Wang,J.W., Mazlan,M.I., Kuan,W.S., Chan,S.P., Peelen,L.M., Grobbee,D.E., Richards,A.M., Lam,C.S.P. and de Kleijn,D.P.V.
    Extracellular vesicle Cystatin C and CD14 are associated with both renal dysfunction and heart failure
    ESC Heart Fail (2020) 7, 2240-2249. PubMed  Europe PubMed DOI
    18. 2019
  18. Wong,W.Y., Wong,H., Au,E. and Chan,E.
    Identification and mapping of a 2,009-bp DNA deletion in SERPING1 of a hereditary angioedema patient
    Case Rep Genet (2019) 2019, 7052062-7052062. PubMed  Europe PubMed DOI  PMC  EPMC  M
    19. 2018
  19. Aygoren-Pursun,E., Bygum,A., Grivcheva-Panovska,V., Magerl,M., Graff,J., Steiner,U.C., Fain,O., Huissoon,A., Kinaciyan,T., Farkas,H., Lleonart,R., Longhurst,H.J., Rae,W., Triggiani,M., Aberer,W., Cancian,M., Zanichelli,A., Smith,W.B., Baeza,M.L., Du-Thanh,A., Gompels,M., Gonzalez-Quevedo,T., Greve,J., Guilarte,M., Katelaris,C., Dobo,S., Cornpropst,M., Clemons,D., Fang,L., Collis,P., Sheridan,W., Maurer,M. and Cicardi,M.
    Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema
    N Engl J Med (2018) 379, 352-362. PubMed  Europe PubMed DOI  I
  20. Caccia,S., Suffritti,C., Carzaniga,T., Berardelli,R., Berra,S., Martorana,V., Fra,A., Drouet,C. and Cicardi,M.
    Intermittent C1-inhibitor deficiency associated with recessive inheritance: functional and structural insight
    Sci Rep (2018) 8, 977-977. PubMed  Europe PubMed DOI  PMC  EPMC  M
  21. Hovingh,E.S., de Maat,S., Cloherty,A.P.M., Johnson,S., Pinelli,E., Maas,C. and Jongerius,I.
    Virulence associated gene 8 of Bordetella pertussis enhances contact system activity by inhibiting the regulatory function of complement regulator C1 inhibitor
    Front Immunol (2018) 9, 1172-1172. PubMed  Europe PubMed DOI  PMC  EPMC
  22. Nilojan,J., Bathige,S.D.N.K., Thulasitha,W.S., Kwon,H., Jung,S., Kim,M.J., Nam,B.H. and Lee,J.
    Transcriptional profiling, molecular cloning, and functional analysis of C1 inhibitor, the main regulator of the complement system in black rockfish, Sebastes schlegelii
    Fish Shellfish Immunol (2018) 75, 263-273. PubMed  Europe PubMed DOI
    23. 2017
  23. Ding,M., Chen,M., Zhong,X., Wang,Y., Fu,S., Yin,X., Guo,Z. and Ye,J.
    Identification and characterization of C1 inhibitor in Nile tilapia (Oreochromis niloticus) in response to pathogenic bacteria
    Fish Shellfish Immunol (2017) 61, 152-162. PubMed  Europe PubMed DOI
  24. Longhurst,H.J.
    Kallikrein inhibition for hereditary angioedema
    N Engl J Med (2017) 376, 788-789. PubMed  Europe PubMed DOI
    25. 2016
  25. Dijk,M., Holkers,J., Voskamp,P., Giannetti,B.M., Waterreus,W.J., van Veen,H.A. and Pannu,N.S.
    How dextran sulfate affects C1-inhibitor activity: a model for polysaccharide potentiation
    Structure (2016) 24, 2182-2189. PubMed  Europe PubMed DOI  S
  26. Ghannam,A., Sellier,P., Fain,O., Martin,L., Ponard,D. and Drouet,C.
    C1 Inhibitor as a glycoprotein: the influence of polysaccharides on its function and autoantibody target
    Mol Immunol (2016) 71, 161-165. PubMed  Europe PubMed DOI
  27. Hermanrud,T., Duus,N., Bygum,A. and Rasmussen,E.R.
    The use of plasma-derived complement C1-esterase inhibitor concentrate (Berinert(R)) in the treatment of angiotensin converting enzyme-inhibitor related angioedema
    Case Rep Emerg Med (2016) 2016, 3930923-3930923. PubMed  Europe PubMed DOI  PMC  EPMC  U
    28. 2015
  28. Lipski,S.M., Casimir,G., Vanlommel,M., Jeanmaire,M. and Dolhen,P.
    Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert(R)): about one case and review of the therapeutic arsenal
    Clin Case Rep (2015) 3, 126-130. PubMed  Europe PubMed DOI  PMC  EPMC  U
  29. Madsen,D.E., Sidelmann,J.J., Biltoft,D., Gram,J. and Hansen,S.
    C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: implication for a role in hereditary angioedema
    Biochim Biophys Acta (2015) 1850, 1336-1342. PubMed  Europe PubMed DOI
    30. 2014
  30. Kumar,A., Bhandari,A., Sarde,S.J. and Goswami,C.
    Molecular phylogeny of C1 inhibitor depicts two immunoglobulin-like domains fusion in fishes and ray-finned fishes specific intron insertion after separation from zebrafish
    Biochem Biophys Res Commun (2014) 450, 219-226. PubMed  Europe PubMed DOI
  31. Tradtrantip,L., Asavapanumas,N., Phuan,P.W. and Verkman,A.S.
    Potential therapeutic benefit of c1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model
    PLoS ONE (2014) 9, e106824-e106824. PubMed  Europe PubMed DOI  PMC  EPMC
  32. Umasuthan,N., Bathige,S.D., Revathy,K.S., Wickramaarachchi,W.D., Wan,Q., Whang,I., Kim,E., Park,M.A., Park,H.C. and Lee,J.
    A C1 inhibitor ortholog from rock bream (Oplegnathus fasciatus): Molecular perspectives of a central regulator in terms of its genomic arrangement, transcriptional profiles and anti-protease activities of recombinant peptide
    Dev Comp Immunol (2014) 42, 197-210. PubMed  Europe PubMed DOI
    33. 2013
  33. Degn,S.E., Thiel,S. and Jensenius,J.C.
    Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitor
    Protein Expr Purif (2013) 88, 173-182. PubMed  Europe PubMed DOI  E
    34. 2011
  34. Caccia,S., Castelli,R., Maiocchi,D., Bergamaschini,L. and Cugno,M.
    Interaction of C1 inhibitor with thrombin on the endothelial surface
    Blood Coagul Fibrinolysis (2011) 22, 571-575. PubMed  Europe PubMed DOI
    35. 2010
  35. Davis,A.E., III, Lu,F. and Mejia,P.
    C1 inhibitor, a multi-functional serine protease inhibitor
    Thromb Haemost (2010) 104, 886-893. PubMed  Europe PubMed DOI  V
  36. Gibson,J., Cree,A., Collins,A., Lotery,A. and Ennis,S.
    Determination of a gene and environment risk model for age-related macular degeneration
    Br J Ophthalmol (2010) 94, 1382-1387. PubMed  Europe PubMed DOI  M
  37. Rossi,V., Bally,I., Ancelet,S., Xu,Y., Fremeaux-Bacchi,V., Vives,R.R., Sadir,R., Thielens,N. and Arlaud,G.J.
    Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding
    J Immunol (2010) 184, 4982-4989. PubMed  Europe PubMed DOI  E
  38. Thorgersen,E.B., Ludviksen,J.K., Lambris,J.D., Sfyroera,G., Nielsen,E.W. and Mollnes,T.E.
    Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity
    Innate Immun (2010) 16, 254-264. PubMed  Europe PubMed DOI
    39. 2009
  39. Gurewich,V. and Pannell,R.
    Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis
    Thromb Haemost (2009) 102, 279-286. PubMed  Europe PubMed DOI
  40. Murray-Rust,T.A., Kerr,F.K., Thomas,A.R., Wu,T., Yongqing,T., Ong,P.C., Quinsey,N.S., Whisstock,J.C., Wagenaar-Bos,I.C., Freeman,C. and Pike,R.N.
    Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1
    Biochem J (2009) 422, 295-303. PubMed  Europe PubMed DOI
    41. 2008
  41. Davis,A.E., III, Mejia,P. and Lu,F.
    Biological activities of C1 inhibitor
    Mol Immunol (2008) 45, 4057-4063. PubMed  Europe PubMed DOI  PMC  EPMC
  42. Frank,M.M. and Jiang,H.
    New therapies for hereditary angioedema: disease outlook changes dramatically
    J Allergy Clin Immunol (2008) 121, 272-280. PubMed  Europe PubMed DOI  V
  43. Wouters,D., Wagenaar-Bos,I., van Ham,M. and Zeerleder,S.
    C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor
    Expert Opin Biol Ther (2008) 8, 1225-1240. PubMed  Europe PubMed DOI  V  U
    44. 2007
  44. Beinrohr,L., Harmat,V., Dobo,J., Lorincz,Z., Gal,P. and Zavodszky,P.
    C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease
    J Biol Chem (2007) 282, 21100-21109. PubMed  Europe PubMed DOI  E  M  S
  45. Davis,A.E., III, Cai,S. and Liu,D.
    C1 inhibitor: biologic activities that are independent of protease inhibition
    Immunobiology (2007) 212, 313-323. PubMed  Europe PubMed DOI  PMC  EPMC  V
  46. Farkas,H., Jakab,L., Temesszentandrasi,G., Visy,B., Harmat,G., Fust,G., Szeplaki,G., Fekete,B., Karadi,I. and Varga,L.
    Hereditary angioedema: A decade of human C1-inhibitor concentrate therapy
    J Allergy Clin Immunol (2007) 120, 941-947. PubMed  Europe PubMed DOI  V
    47. 2006

  47. C1 Esterase Inhibitor
     (2006) PubMed  Europe PubMed
  48. [YEAR:22-8-2006]Fu,J., Lin,G., Wu,Z., Ceng,B., Wu,Y., Liang,G., Qin,G., Li,J., Chiu,I. and Liu,D.
    Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury
    Biochem Biophys Res Commun (22-8-2006) 349, 504-512. PubMed  Europe PubMed DOI
    49. 2005
  49. [YEAR:15-5-2005]Cai,S., Dole,V.S., Bergmeier,W., Scafidi,J., Feng,H., Wagner,D.D. and Davis,A.E., III
    A direct role for C1 inhibitor in regulation of leukocyte adhesion
    J Immunol (15-5-2005) 174, 6462-6466. PubMed  Europe PubMed
  50. Cicardi,M., Zingale,L., Zanichelli,A., Pappalardo,E. and Cicardi,B.
    C1 inhibitor: molecular and clinical aspects
    Springer Semin Immunopathol (2005) 27, 286-298. PubMed  Europe PubMed DOI  V
    51. 2004
  51. [YEAR:1-6-2004]Bos,I.G., Lubbers,Y.T., Eldering,E., Abrahams,J.P. and Hack,C.E.
    Effect of reactive site loop elongation on the inhibitory activity of C1-inhibitor
    Biochim Biophys Acta (1-6-2004) 1699, 139-144. PubMed  Europe PubMed DOI
  52. Davis,A.E., III
    Biological effects of C1 inhibitor
    Drug News Perspect (2004) 17, 439-446. PubMed  Europe PubMed DOI  V
  53. Ravindran,S., Grys,T.E., Welch,R.A., Schapira,M. and Patston,P.A.
    Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor
    Thromb Haemost (2004) 92, 1277-1283. PubMed  Europe PubMed DOI
    54. 2003
  54. Cumming,S.A., Halsall,D.J., Ewan,P.W. and Lomas,D.A.
    The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angio-oedema
    J Med Genet (2003) 40, e114-e114. PubMed  Europe PubMed  PMC  EPMC
    55. 2002
  55. Brown,E.W., Ravindran,S. and Patston,P.A.
    The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism
    Blood Coagul Fibrinolysis (2002) 13, 711-714. PubMed  Europe PubMed DOI
  56. Lathem,W.W., Grys,T.E., Witowski,S.E., Torres,A.G., Kaper,J.B., Tarr,P.I. and Welch,R.A.
    StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor
    Mol Microbiol (2002) 45, 277-288. PubMed  Europe PubMed DOI
    57. 2001
  57. [YEAR:1-8-2001]Zahedi,R., MacFarlane,R.C., Wisnieski,J.J. and Davis,A.E., III
    C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition
    J Immunol (1-8-2001) 167, 1500-1506. PubMed  Europe PubMed
    58. 1998
  58. [YEAR:15-10-1998]Heeb,M.J. and Espana,F.
    alpha2-Macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein
    Blood Cells Mol Dis (15-10-1998) 24, 412-419. PubMed  Europe PubMed DOI
    59. 1995
  59. Patston,P.A., Qi,M., Schifferli,J.A. and Schapira,M.
    The effect of cleavage by a Crotalus atrox alpha-proteinase fraction on the properties of C1-inhibitor
    Toxicon (1995) 33, 53-61. PubMed  Europe PubMed DOI
    60. 1993
  60. Aulak,K.S., Davis,A.E., III, Donaldson,V.H. and Harrison,R.A.
    Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers
    Protein Sci (1993) 2, 727-732. PubMed  Europe PubMed DOI  PMC  EPMC
  61. Davis,A.E., III, Aulak,K.S., Zahedi,K., Bissler,J.J. and Harrison,R.A.
    C1 inhibitor
    Methods Enzymol (1993) 223, 97-120. PubMed  Europe PubMed DOI  V
  62. Suzuki,K.
    Protein C inhibitor
    Methods Enzymol (1993) 222, 385-399. PubMed  Europe PubMed DOI  V
    63. 1987
  63. [YEAR:15-6-1987]Faulmann,E.L., Young,M. and Boyle,M.D.
    Inactivation of the proteolytic activity of mouse nerve growth factor by human C1(activated)-inhibitor
    J Immunol (15-6-1987) 138, 4336-4340. PubMed  Europe PubMed
    64. 1986
  64. Wiman,B.
    Human C1-inhibitor
    [ISSN:0-444-80763-2] (1986) , 477-488.  V
    65. 1985
  65. Donaldson,V.H., Harrison,R.A., Rosen,F.S., Bing,D.H., Kindness,G., Canar,J., Wagner,C.J. and Awad,S.
    Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies
    J Clin Invest (1985) 75, 124-132. PubMed  Europe PubMed DOI  PMC  EPMC
  66. [YEAR:25-2-1985]Salvesen,G.S., Catanese,J.J., Kress,L.F. and Travis,J.
    Primary structure of the reactive site of human C1-inhibitor
    J Biol Chem (25-2-1985) 260, 2432-2436. PubMed  Europe PubMed
    67. 1984
  67. de Agostini,A., Lijnen,H.R., Pixley,R.A., Colman,R.W. and Schapira,M.
    Inactivation of factor XII active fragment in normal plasma. Predominant role of C1-inhibitor
    J Clin Invest (1984) 73, 1542-1549. PubMed  Europe PubMed DOI  PMC  EPMC
    68. 1983
  68. [YEAR:11-10-1983]Harrison,R.A.
    Human C1 inhibitor: improved isolation and preliminary structural characterization
    Biochemistry (11-10-1983) 22, 5001-5007. PubMed  Europe PubMed
  69. Nilsson,T. and Wiman,B.
    Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s
    Eur J Biochem (1983) 129, 663-667. PubMed  Europe PubMed
  70. [YEAR:1-9-1983]Nilsson,T., Sjoholm,I. and Wiman,B.
    Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s
    Biochem J (1-9-1983) 213, 617-624. PubMed  Europe PubMed  PMC  EPMC
  71. [YEAR:14-3-1983]Wiman,B. and Nilsson,T.
    A new simple method for determination of C1-esterase inhibitor activity in plasma
    Clin Chim Acta (14-3-1983) 128, 359-366. PubMed  Europe PubMed
    72. 1982
  72. Caughman,G.B., Boackle,R.J. and Vesely,J.
    A postulated mechanism for heparin's potentiation of C1 inhibitor function
    Mol Immunol (1982) 19, 287-295. PubMed  Europe PubMed DOI
  73. [YEAR:1-1-1982]Chesne,S., Villiers,C.L., Arlaud,G.J., Lacroix,M.B. and Colomb,M.G.
    Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1
    Biochem J (1-1-1982) 201, 61-70. PubMed  Europe PubMed  PMC  EPMC
  74. [YEAR:26-7-1982]Nilsson,T. and Wiman,B.
    Purification and characterization of human C1-esterase inhibitor
    Biochim Biophys Acta (26-7-1982) 705, 271-276. PubMed  Europe PubMed
  75. Schapira,M., Silver,L.D., Scott,C.F. and Colman,R.W.
    New and rapid functional assay for C1 inhibitor in human plasma
    Blood (1982) 59, 719-724. PubMed  Europe PubMed
    76. 1981
  76. Sim,R.B. and Reboul,A.
    Preparation and properties of human C1úbarú inhibitor
    Methods Enzymol (1981) 80, 43-54. PubMed  Europe PubMed DOI  V
    77. 1980
  77. [YEAR:11-4-1980]Sim,R.B., Arlaud,G.J. and Colomb,M.G.
    Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s
    Biochim Biophys Acta (11-4-1980) 612, 433-449. PubMed  Europe PubMed
    78. 1979
  78. [YEAR:25-1-1979]Arlaud,G.J., Reboul,A., Sim,R.B. and Colomb,M.G.
    Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1
    Biochim Biophys Acta (25-1-1979) 576, 151-162. PubMed  Europe PubMed
  79. [YEAR:1-1-1979]Sim,R.B., Reboul,A., Arlaud,G.J., Villiers,C.L. and Colomb,M.G.
    Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma
    FEBS Lett (1-1-1979) 97, 111-115. PubMed  Europe PubMed DOI
  80. [YEAR:1-6-1979]Sim,R.B., Arlaud,G.J. and Colomb,M.G.
    C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes
    Biochem J (1-6-1979) 179, 449-457. PubMed  Europe PubMed  PMC  EPMC
    81. 1977
  81. [YEAR:1-7-1977]Reboul,A., Arlaud,G.J., Sim,R.B. and Colomb,M.G.
    A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s
    FEBS Lett (1-7-1977) 79, 45-50. PubMed  Europe PubMed DOI
    82. 1976
  82. Harpel,P.C.
    C1 inactivator
    Methods Enzymol (1976) 45, 751-750. PubMed  Europe PubMed DOI  V
    83. 1975
  83. Harpel,P.C. and Cooper,N.R.
    Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin
    J Clin Invest (1975) 55, 593-604. PubMed  Europe PubMed DOI  PMC  EPMC
  84. [YEAR:20-10-1975]Owen,W.G.
    Evidence for the formation of an ester between thrombin and heparin cofactor
    Biochim Biophys Acta (20-10-1975) 405, 380-387. PubMed  Europe PubMed
    85. 1970
  85. Forbes,C.D., Pensky,J. and Ratnoff,O.D.
    Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator
    J Lab Clin Med (1970) 76, 809-815. PubMed  Europe PubMed
  86. Haupt,H., Heimburger,N., Kranz,T. and Schwick,H.G.
    [Isolation and characterization of C1-Inactivator from human plasma]
    Eur J Biochem (1970) 17, 254-261. PubMed  Europe PubMed
    87. 1969
  87. Ratnoff,O.D., Pensky,J., Ogston,D. and Naff,G.B.
    The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor
    J Exp Med (1969) 129, 315-331. PubMed  Europe PubMed  PMC  EPMC
    88. 1961
  88. Pensky,J., Levy,L.R. and Lepow,I.H.
    Partial purification of a serum inhibitor of C'1-esterase
    J Biol Chem (1961) 236, 1674-1679. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use